With the QIAGEN nanoplate-based dPCR system, clinical scientists find better ways to diagnose invasive fungal disease and side-step antifungal therapy resistance
Experts discuss the game-changing potential of novel host response-based diagnostics to combat the global challenge of antimicrobial resistance (AMR)
Research partnership aims to build strong pharma and academic collaborations in sharing data and clinical samples to develop biomarker-based diagnostics for Alzheimer’s disease
Discover how Alturas Analytics offers LC-MS/MS and GC-MS/MS bioanalytical services that support drug developers and enables them to gain a competitive edge in the marketplace
A panel of experienced specialists explore the significance of single-use technology (SUT) in biopharmaceutical manufacturing and biotechnology
Jiseon Kim, Senior Scientist at ProGen, explores the transformative potential of a bispecific antibody-based drug to lay the foundation for improved healthcare quality
The collaboration aims to utilize high-quality reagent materials, develop new parameters, and advance technologies in the future
Portable testing platforms are set to drive precision medicine and community health into 2024, so when will they see a more widespread adoption amongst healthcare providers and individuals alike?
Watch this on-demand webinar to learn about monoclonal antibody-based human immune modulation in enhancing therapeutic outcomes
Test could allow clinicians to screen for individuals at high risk of developing the disease and facilitate the introduction of precision therapies that are at clinical trial stage
Expanding biocatalyst solutions will reduce energy use and waste in pharmaceutical and agrochemical industries
